Details of the Drug

General Information of Drug (ID: DMDDG4Y)

Drug Name
K22
Synonyms (Z)-N-(3-(4-(4-bromophenyl)-4-hydroxypiperidin-1-yl)-3-oxo-1-phenylprop-1-en-2-yl)benzamide
Indication
Disease Entry ICD 11 Status REF
Middle East Respiratory Syndrome (MERS) 1D64 Preclinical [1]
Severe acute respiratory syndrome (SARS) 1D65 Preclinical [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C7H2Br4N2S
Canonical SMILES
C12=C(C(=C(C(=C1Br)Br)Br)Br)NC(=S)N2
InChI
InChI=1S/C7H2Br4N2S/c8-1-2(9)4(11)6-5(3(1)10)12-7(14)13-6/h(H2,12,13,14)
InChIKey
GYVCACUYQFXPLN-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
9981969
ChEBI ID
CHEMBL608394
TTD ID
D0X5GF
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virus. PLoS Pathog. 2014 May 29;10(5):e1004166.